158 related articles for article (PubMed ID: 34849208)
1. Structure based prediction of a novel GPR120 antagonist based on pharmacophore screening and molecular dynamics simulations.
Pal A; Curtin JF; Kinsella GK
Comput Struct Biotechnol J; 2021; 19():6050-6063. PubMed ID: 34849208
[TBL] [Abstract][Full Text] [Related]
2. In silico and in vitro screening for potential anticancer candidates targeting GPR120.
Pal A; Curtin JF; Kinsella GK
Bioorg Med Chem Lett; 2021 Jan; 31():127672. PubMed ID: 33161126
[TBL] [Abstract][Full Text] [Related]
3. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
Zeng L; Guan M; Jin H; Liu Z; Zhang L
Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
[TBL] [Abstract][Full Text] [Related]
4. A new insight into identification of in silico analysis of natural compounds targeting GPR120.
Chinthakunta N; Cheemanapalli S; Chinthakunta S; Anuradha CM; Chitta SK
Netw Model Anal Health Inform Bioinform; 2018; 7(1):8. PubMed ID: 29780684
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
6. Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice.
Murtaza B; Hichami A; Khan AS; Shimpukade B; Ulven T; Ozdener MH; Khan NA
J Lipid Res; 2020 Feb; 61(2):133-142. PubMed ID: 31806728
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis.
Wang X; He S; Gu Y; Wang Q; Chu X; Jin M; Xu L; Wu Q; Zhou Q; Wang B; Zhang Y; Wang H; Zheng L
EBioMedicine; 2019 Feb; 40():251-262. PubMed ID: 30738829
[TBL] [Abstract][Full Text] [Related]
8. Free fatty acid receptors beyond fatty acids: A computational journey to explore peptides as possible binders of GPR120.
Pedroni L; Perugino F; Magnaghi F; Dall'Asta C; Galaverna G; Dellafiora L
Curr Res Food Sci; 2024; 8():100710. PubMed ID: 38496766
[TBL] [Abstract][Full Text] [Related]
9. Activation of GPR120 by TUG891 ameliorated cisplatin-induced acute kidney injury via repressing ER stress and apoptosis.
Huang Z; Guo F; Xia Z; Liang Y; Lei S; Tan Z; Ma L; Fu P
Biomed Pharmacother; 2020 Jun; 126():110056. PubMed ID: 32145589
[TBL] [Abstract][Full Text] [Related]
10. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
11. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
Saxena S; Abdullah M; Sriram D; Guruprasad L
J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
[TBL] [Abstract][Full Text] [Related]
13. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
14. Computational modeling toward understanding agonist binding on dopamine 3.
Zhao Y; Lu X; Yang CY; Huang Z; Fu W; Hou T; Zhang J
J Chem Inf Model; 2010 Sep; 50(9):1633-43. PubMed ID: 20695484
[TBL] [Abstract][Full Text] [Related]
15. An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies.
Kanan D; Kanan T; Dogan B; Orhan MD; Avsar T; Durdagi S
ChemMedChem; 2021 Feb; 16(3):555-567. PubMed ID: 33063944
[TBL] [Abstract][Full Text] [Related]
16. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
[TBL] [Abstract][Full Text] [Related]
17. FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.
Takeuchi M; Hirasawa A; Hara T; Kimura I; Hirano T; Suzuki T; Miyata N; Awaji T; Ishiguro M; Tsujimoto G
Br J Pharmacol; 2013 Apr; 168(7):1570-83. PubMed ID: 22639973
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent Ligand-Based Discovery of Small-Molecule Sulfonamide Agonists for GPR120.
Ma S; Li Z; Yang Y; Zhang L; Li M; Du L
Front Chem; 2022; 10():816014. PubMed ID: 35174139
[TBL] [Abstract][Full Text] [Related]
19. A novel anti-inflammatory role of GPR120 in intestinal epithelial cells.
Anbazhagan AN; Priyamvada S; Gujral T; Bhattacharyya S; Alrefai WA; Dudeja PK; Borthakur A
Am J Physiol Cell Physiol; 2016 Apr; 310(7):C612-21. PubMed ID: 26791484
[TBL] [Abstract][Full Text] [Related]
20. Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma.
Wu Q; Wang H; Zhao X; Shi Y; Jin M; Wan B; Xu H; Cheng Y; Ge H; Zhang Y
Oncogene; 2013 Dec; 32(49):5541-50. PubMed ID: 23851494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
